Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M

A San Diego biotech is working on therapies that could tackle life-altering conditions, like autoimmune diseases and cancer, by modifying cells. But instead of engineering cells in a lab, they’re doing it inside your body

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...